ROBERT W. ROSS - 01 Aug 2023 Form 4 Insider Report for Surface Oncology, Inc.

Role
Chief Executive Officer
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Aug 2023
Net transactions value
-$15,710
Form type
4
Filing time
11 Aug 2023, 20:00:09 UTC
Previous filing
13 Jun 2023
Next filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SURF Common Stock Sale $15,710 -16,713 -17% $0.9400 83,193 01 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.